Literature DB >> 15811694

Vibration induced hearing loss in guinea pig cochlea: expression of TNF-alpha and VEGF.

Jing Zou1, Ilmari Pyykkö, Päivi Sutinen, Esko Toppila.   

Abstract

Transcranial vibration was applied for seven animals at a frequency of 250 Hz for 15 min, and five animals were used as normal controls to investigate cellular and molecular mechanism linked to vibration-induced hearing loss in animal model. Compound action potential (CAP) thresholds were measured by round window niche electrode. The expression of tumour necrosis factor alpha (TNF-alpha) and its receptors (TNF R1, TNF R2), vascular endothelium growth factor (VEGF) and its receptors (VEGF R1, VEGF R2) were analysed by immunohistochemistry. Transcranial vibration caused expression of TNF-alpha, TNF R1 and TNF R2 in the cochlea and the expression of TNF R2 was stronger than that of TNF R1. Vibration also induced VEGF and VEGF R2 expression in the cochlea. The average immediate hearing loss was 62 dB and after three days still 48 dB. It is concluded that transcranial vibration as during temporal bone drilling produces cochlear shear stress that is connected with up-regulation of TNF-alpha and its receptors. Also VEGF and VEGF R2 are up-regulated. These responses may be linked to both the damage and repair process of the cochlea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811694     DOI: 10.1016/j.heares.2004.10.008

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  23 in total

1.  Tumor necrosis factor-alpha-mutant mice exhibit high frequency hearing loss.

Authors:  Naoki Oishi; Jun Chen; Hong-Wei Zheng; Kayla Hill; Jochen Schacht; Su-Hua Sha
Journal:  J Assoc Res Otolaryngol       Date:  2013-08-31

Review 2.  Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.

Authors:  Colleen G Le Prell; Daisuke Yamashita; Shujiro B Minami; Tatsuya Yamasoba; Josef M Miller
Journal:  Hear Res       Date:  2006-12-04       Impact factor: 3.208

3.  Transplantation of mouse embryonic stem cells into the cochlea of an auditory-neuropathy animal model: effects of timing after injury.

Authors:  Hainan Lang; Bradley A Schulte; John C Goddard; Michelle Hedrick; Jason B Schulte; Ling Wei; Richard A Schmiedt
Journal:  J Assoc Res Otolaryngol       Date:  2008-05-01

4.  Changes in Gene Expression and Hearing Thresholds After Cochlear Implantation.

Authors:  Hongzheng Zhang; Gemaine Stark; Lina Reiss
Journal:  Otol Neurotol       Date:  2015-08       Impact factor: 2.311

5.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

6.  Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling.

Authors:  Elias Q Scherer; Jingli Yang; Martin Canis; Katrin Reimann; Karolina Ivanov; Christian D Diehl; Peter H Backx; W Gil Wier; Sebastian Strieth; Philine Wangemann; Julia Voigtlaender-Bolz; Darcy Lidington; Steffen-Sebastian Bolz
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

7.  TAK1 expression in the cochlea: a specific marker for adult supporting cells.

Authors:  Mark A Parker; Kevin Jiang; Judith S Kempfle; Kunio Mizutari; Caitlin L Simmons; Rebecca Bieber; Joe Adams; Albert S B Edge
Journal:  J Assoc Res Otolaryngol       Date:  2011-04-07

Review 8.  Erythropoietin but not VEGF has a protective effect on auditory hair cells in the inner ear.

Authors:  Arianne Monge Naldi; Max Gassmann; Daniel Bodmer
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

9.  Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss.

Authors:  István Sziklai; Tamás József Batta; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

10.  Macrophage migration inhibitory factor acts as a neurotrophin in the developing inner ear.

Authors:  Lisa M Bank; Lynne M Bianchi; Fumi Ebisu; Dov Lerman-Sinkoff; Elizabeth C Smiley; Yu-chi Shen; Poornapriya Ramamurthy; Deborah L Thompson; Therese M Roth; Christine R Beck; Matthew Flynn; Ryan S Teller; Luming Feng; G Nicholas Llewellyn; Brandon Holmes; Cyrrene Sharples; Jaeda Coutinho-Budd; Stephanie A Linn; Andrew P Chervenak; David F Dolan; Jennifer Benson; Ariane Kanicki; Catherine A Martin; Richard Altschuler; Alisa E Koch; Alicia E Koch; Ethan M Jewett; John A Germiller; Kate F Barald
Journal:  Development       Date:  2012-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.